XML 48 R19.htm IDEA: XBRL DOCUMENT v3.21.2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)
3 Months Ended
Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
Schedule of impact of restatement on the balance sheets and statements of operations

As of December 31, 2020

As Previously

Restatement

    

Reported

    

Adjustment

    

As Restated

Balance Sheet

 

  

 

  

 

  

Total assets

$

416,346,780

$

$

416,346,780

Liabilities and Shareholders’ equity

 

  

 

  

 

  

Total current liabilities

$

416,521

$

$

416,521

Deferred underwriting commissions

 

14,490,000

 

 

14,490,000

Derivative liabilities

 

 

40,532,280

 

40,532,280

Total liabilities

 

14,906,521

 

40,532,280

 

55,438,801

Class A ordinary shares, $0.0001 par value; shares subject to possible redemption

 

396,440,250

 

(40,532,280)

 

355,907,970

Shareholders’ equity

 

  

 

  

 

  

Preference shares - $0.0001 par value

 

 

 

Class A ordinary shares - $0.0001 par value

 

176

 

405

 

581

Class B ordinary shares - $0.0001 par value

 

1,035

 

 

1,035

Additional paid-in-capital

 

5,013,277

 

11,784,745

 

16,798,022

Accumulated deficit

 

(14,479)

 

(11,785,150)

 

(11,799,629)

Total shareholders’ equity

 

5,000,009

 

 

5,000,009

Total liabilities and shareholders’ equity

$

416,346,780

$

$

416,346,780

Period From September 28, 2020 (Inception)
Through December 31, 2020

As Previously 

Restatement 

    

Reported

    

Adjustment

    

As Restated

Statement of Operations

 

  

 

  

 

  

Loss from operations

$

(35,004)

$

(35,004)

 

  

Other (expense) income:

 

  

 

  

 

  

Change in fair value of derivative liabilities

 

 

(10,659,080)

 

(10,659,080)

Transaction costs - derivative liabilities

 

 

(1,126,070)

 

(1,126,070)

Net gain from investments held in Trust Account

 

20,525

 

 

20,525

Total other (expense) income

 

20,525

 

(11,785,150)

 

(11,764,625)

Net loss

$

(14,479)

$

(11,785,150)

$

(11,799,629)

Basic and Diluted weighted-average Class A ordinary common stock

 

41,400,000

 

 

41,400,000

Basic and Diluted net loss per Class A share

$

0.00

 

$

0.00

Basic and Diluted weighted-average Class B ordinary common stock

 

10,350,000

 

 

10,350,000

Basic and Diluted net loss per Class B share

$

(0.00)

 

(1.14)

$

(1.14)

As of December 15, 2020

As Previously

Restatement

    

Reported

    

Adjustment

    

As Restated

Balance Sheet

 

  

 

  

 

  

Total assets

$

416,788,700

$

$

416,788,700

Liabilities and Shareholders’ equity

 

  

 

  

 

  

Total current liabilities

$

762,402

$

$

762,402

Deferred underwriting fee payable

 

14,490,000

 

 

14,490,000

Derivative liabilities

 

 

29,873,200

 

29,873,200

Total liabilities

 

15,252,402

 

29,873,200

 

45,125,602

Class A ordinary shares, $0.0001 par value; shares subject to possible redemption

 

396,536,290

 

(29,873,200)

 

366,663,090

Shareholders’ equity

 

  

 

  

 

  

Preference shares - $0.0001 par value

 

 

 

Class A ordinary shares - $0.0001 par value

 

175

 

298

 

473

Class B ordinary shares - $0.0001 par value

 

1,035

 

 

1,035

Additional paid-in-capital

 

5,003,798

 

1,125,772

 

6,129,570

Accumulated deficit

 

(5,000)

 

(1,126,070)

 

(1,131,070)

Total shareholders’ equity

 

5,000,008

 

 

5,000,008

Total liabilities and shareholders’ equity

$

416,788,700

$

$

416,788,700